OmarAliMatherMD

Pediatrics • Thousand Oaks, CA

Executive Medical Director, Clinical Safety and Risk Management Physician, at Merck

Join to view full profile

Dr. Mather is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mather's full profile

Already have an account?

Office
123 Nunya Business Lane
Thousand Oaks, CA 91360

Education & Training

Children's Hospital Los AngelesResidency, Pediatrics, 2006 - 2009
The University of Toledo College of MedicineClass of 2006

Certifications & Licensure

CA State Medical License 2008 - 2026
American Board of Pediatrics Pediatrics

Publications & Presentations

PubMed

1 citations
A Phase 1, Open-Label Study to Evaluate the Effect of Food and Concomitant Itraconazole Administration on the Pharmacokinetics of AMG 986 in Healthy Subjects.
Ashit Trivedi, Omar Mather, Silvia Vega, Shauna Hutton, Jennifer Hellawell
Clinical Pharmacology in Drug Development. 2022-07-01
2 citations
A Phase I, Open-label, Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of AMG 986 in Healthy Japanese Subjects.
Ashit Trivedi, Omar Mather, Silvia Vega, Shauna Hutton, Jennifer Hellawell
Drugs in R&D. 2022-06-01
2 citations
Evaluation of the Pharmacokinetics and Safety of AMG 986 Tablet and Capsule Formulations in Healthy Adult Subjects: A Phase I, Open-Label, Randomized Study.
Ashit Trivedi, Y-H Kiang, Robert E Saw, Guilong Charles Cheng, Omar Mather
Drugs in R&D. 2022-06-01